Shan, Naing Lin http://orcid.org/0000-0002-8572-1311
Kahn, Adriana
Pusztai, Lajos http://orcid.org/0000-0001-9632-6686
Article History
Received: 8 September 2022
Revised: 27 September 2022
Accepted: 29 September 2022
First Online: 10 October 2022
Competing interests
: LP has received consulting fees and honoraria from Pfizer, AstraZeneca, Merck, Novartis, Bristol-Myers Squibb, GlaxoSmithKline, Genentech, Personalis, Daiichi, Natera, Exact Sciences and institutional research funding from Seagen, GlaxoSmithKline, AstraZeneca, Merck, Pfizer and Bristol-Myers Squibb.
: Not applicable.
: Not applicable.